Roivant Sciences (ROIV) analyst forecast and price target
Analyst forecast
Consensus of 13 analyst ratings
Based on 3 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $41.00 | Aug 28, 2026 |
| Citigroup | Maintained | Buy | $46.00 from $42.00 | Aug 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $41.00 from $34.00 | Aug 7, 2026 |
| Guggenheim | Maintained | Buy | $42.00 from $36.00 | Aug 7, 2026 |
| Guggenheim | Maintained | Buy | $36.00 from $30.00 | May 26, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $34.00 | May 21, 2026 |
| Citigroup | Maintained | Buy | $42.00 from $35.00 | May 21, 2026 |
| TD Cowen | Maintained | Buy | $41.00 from $38.00 | May 21, 2026 |
| Piper Sandler | Maintained | Overweight | $40.00 from $22.00 | Apr 16, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $34.00 from $33.00 | Mar 4, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $33.00 from $26.00 | Feb 10, 2026 |
| Citigroup | Maintained | Buy | $35.00 from $26.00 | Feb 10, 2026 |
| Guggenheim | Maintained | Buy | $30.00 from $28.00 | Feb 9, 2026 |
| Goldman Sachs | Maintained | Buy | $33.00 from $24.00 | Dec 15, 2025 |
| Leerink Partners | Maintained | Outperform | $32.00 from $29.00 | Dec 15, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $26.00 from $23.00 | Dec 12, 2025 |
| Citigroup | Maintained | Buy | $26.00 from $25.00 | Nov 11, 2025 |
| Citigroup | Maintained | Buy | $25.00 from $16.00 | Oct 29, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 from $18.00 | Sep 18, 2025 |
| Leerink Partners | Maintained | Outperform | $22.00 from $18.00 | Sep 18, 2025 |
Frequently asked questions
What is the price target for ROIV stock?
The average 12-month analyst price target for Roivant Sciences (ROIV) is $43.00, with a high estimate of $46.00 and a low of $41.00, across 3 analysts.
Is ROIV a buy, sell, or hold?
Analysts covering Roivant Sciences currently average a Buy rating: 12 buy, 1 hold and 0 sell, from 13 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for ROIV?
The average price target of $43.00 implies 24.13% upside from the last price of $34.64.
What is the latest analyst rating on ROIV?
On Aug 28, 2026, HC Wainwright & Co. maintained Roivant Sciences at Buy with a price target of $41.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.